Kevin Carey

Portrait
Kevin Carey, VP, Program & Alliance Management

Kevin Carey joined Citius Pharmaceuticals with more than 25 years of experience in global pharmaceutical development, regulatory strategy, alliance management, and program execution. He has led cross-functional drug development programs from early-stage clinical trials through regulatory submission and commercialization across a broad range of therapeutic areas, including oncology, infectious disease, immunology, rare and orphan diseases, dermatology, and pain management.



Prior to joining Citius, Mr. Carey served as Senior Director and Head of the Program Management Office at Dr. Reddy’s Laboratories, where he led the development, approval, and out-licensing of multiple FDA-approved products, including Tosymra®, Elyxyb®, Impoyz®, and Sernivo®. He oversaw a $500M proprietary portfolio spanning 12+ development programs, established global PMO governance frameworks, and built an alliance management function that supported strategic partnerships and licensing agreements. Earlier in his tenure at Dr. Reddy’s, Mr. Carey held director- and associate director-level roles in program management, where he led the development of Sernivo® and supported clinical execution, NDA submission, and commercialization for several dermatology and pain programs.



Mr. Carey’s experience also includes product development leadership roles at ProStrakan, where he directed the advancement and approval of Fortesta®, Rectiv®, Sancuso®, and Abstral®. At Barrier Therapeutics, he built and led the PMO function, managing dermatology-focused development programs from IND through commercialization. He began his career in program and engineering roles at AstraZeneca and Becton Dickinson, contributing to early-stage development and operational execution.



Mr. Carey earned his Bachelor of Science in Materials Science from North Carolina State University. He is a member of the Project Management Institute (PMI) and the Regulatory Affairs Professionals Society (RAPS), and is a frequent speaker on the topics of program execution, alliance governance, and scaling PMOs in emerging biotech organizations.